Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,930 | -247,553 | -185,747 | -125,866 | -73,026 |
| Depreciation Amortization | 2,116 | 10,942 | 7,863 | 6,096 | 2,830 |
| Accounts receivable | -765 | -14,863 | -11,493 | -9,834 | -1,941 |
| Accounts payable and accrued liabilities | -8,544 | 8,374 | -2,821 | -4,918 | 2,567 |
| Other Working Capital | -26,627 | -47,267 | -42,255 | -40,095 | -25,205 |
| Other Operating Activity | 29,494 | 78,505 | 67,657 | 48,514 | 16,153 |
| Operating Cash Flow | $-79,256 | $-211,862 | $-166,796 | $-126,103 | $-78,622 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,130 | -8,754 | -4,190 | -3,918 | -2,524 |
| Purchase Of Investment | N/A | -57,936 | -57,936 | -57,936 | -57,936 |
| Sale Of Investment | 29,134 | 384,002 | 333,828 | 261,738 | 151,586 |
| Investing Cash Flow | $28,004 | $317,312 | $271,702 | $199,884 | $91,126 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 74,799 | N/A | N/A | N/A |
| Common Stock Issued | 3,703 | 17,608 | 16,574 | 11,000 | 2,968 |
| Other Financing Activity | -1,923 | -5,287 | -5,293 | -2,302 | -2,184 |
| Financing Cash Flow | $1,780 | $87,120 | $11,281 | $8,698 | $784 |
| Beginning Cash Position | 497,202 | 304,632 | 304,632 | 304,632 | 304,632 |
| End Cash Position | 447,730 | 497,202 | 420,819 | 387,111 | 317,920 |
| Net Cash Flow | $-49,472 | $192,570 | $116,187 | $82,479 | $13,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,256 | -211,862 | -166,796 | -126,103 | -78,622 |
| Capital Expenditure | -1,130 | -8,754 | -4,190 | -3,918 | -2,524 |
| Free Cash Flow | -80,386 | -220,616 | -170,986 | -130,021 | -81,146 |